107 related articles for article (PubMed ID: 7515671)
21. Nucleolar organizer regions (NORs) in adenomyosis.
Madej P; Plewka A; Madej JA; Plewka D; Rutkowski T
Pathol Res Pract; 2006; 202(6):433-7. PubMed ID: 16513291
[TBL] [Abstract][Full Text] [Related]
22. Digital image analysis of mean AgNOR area objectively discriminates between reactive plasmacytosis and multiple myeloma in cytologic smears from bone marrow aspirates.
Gunia S; Mai PA; Koch S
Pathobiology; 2008; 75(5):306-11. PubMed ID: 18931533
[TBL] [Abstract][Full Text] [Related]
23. Cathepsin B, p53 expression and AgNORs in transitional cell carcinoma.
Akpolat I; Bariş YS; Yilmaz AF; Bakirtaş M; Saylik A; Karagöz F; Kandemir B
Neoplasma; 1998; 45(6):365-8. PubMed ID: 10210109
[TBL] [Abstract][Full Text] [Related]
24. [Agyrophilic nucleolar organizer region counts as related to bromodeoxyuridine incorporation scores in ovarian clear cell carcinoma cells].
Huang HX
Zhonghua Zhong Liu Za Zhi; 1992 Mar; 14(2):87-90. PubMed ID: 1377622
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic value of AgNOR method in thyroid cytopathology: correlation with morphometric measurements.
Solymosi T; Tóth V; Sápi Z; Bodó M; Gál I; Csanádi L
Diagn Cytopathol; 1996 Mar; 14(2):140-4. PubMed ID: 8964170
[TBL] [Abstract][Full Text] [Related]
26. [Significance of the AgNOR in tumor pathology].
Pich A; Margaria E; Chiusa L
Pathologica; 2002 Feb; 94(1):2-9. PubMed ID: 11912874
[TBL] [Abstract][Full Text] [Related]
27. Standardized AgNOR analysis of the invasive tumour front in oral squamous cell carcinomas.
Piffkò J; Bànkfalvi A; Ofner D; Rasch D; Joos U; Schmid KW
J Pathol; 1997 Aug; 182(4):450-6. PubMed ID: 9306967
[TBL] [Abstract][Full Text] [Related]
28. [Use of the AgNOR method for the differential diagnosis of tumors and for the quantification of non-neoplastic epidermal hyperproliferation in dermatohistology].
Heinisch G; Barth J
Zentralbl Pathol; 1994 Mar; 140(1):95-101. PubMed ID: 7515680
[TBL] [Abstract][Full Text] [Related]
29. Value of AgNORS in fine needle aspiration cytology of breast lesions.
Rajeevan K; Aravindan KP; Kumari BC
Indian J Pathol Microbiol; 1995 Jan; 38(1):17-24. PubMed ID: 8919465
[TBL] [Abstract][Full Text] [Related]
30. Modified silver staining of nucleolar organizer regions to improve the accuracy of image analysis.
Orrea SC; Tomasi VH; Schwint AE; Itoiz ME
Biotech Histochem; 2001 Mar; 76(2):67-73. PubMed ID: 11440307
[TBL] [Abstract][Full Text] [Related]
31. [Functional morphology of nucleolus organizer regions of chromosomes and nucleoli in human multiple myeloma cell lines. I. Variation of the morphology and silver staining of nucleolus organizer regions of chromosomes in RMPI 8226 and U 266 cell lines with different level of differentiation of during 7 days after cell passage].
Turilova VI; Smirnova TD; Samoĭlovich MP; Sukhikh TR
Tsitologiia; 1998; 40(6):536-48. PubMed ID: 9778736
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of nucleolus organizer regions (NORs) by automatic image analysis: a contribution to standardization.
Rüschoff J; Plate KH; Contractor H; Kern S; Zimmermann R; Thomas C
J Pathol; 1990 Jun; 161(2):113-8. PubMed ID: 1696312
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of quantitatively measured AgNORs in ductal mammary carcinoma.
Aubele M; Auer G; Jütting U; Falkmer U; Gais P
Anal Quant Cytol Histol; 1994 Jun; 16(3):211-8. PubMed ID: 7522453
[TBL] [Abstract][Full Text] [Related]
34. Morphometry and digital AgNOR analysis in cytological imprints of benign, borderline and malignant serous ovarian tumours.
Stemberger-Papić S; Stanković T; Vrdoljak-Mozetic D; Versa-Ostojić D; Krasević M; Stifter S; Audy-Jurković S
Cytopathology; 2006 Dec; 17(6):382-9. PubMed ID: 17168922
[TBL] [Abstract][Full Text] [Related]
35. Location of nucleolar organizer regions (AgNORs) in the nuclei of astrocytic tumors.
Pedal WP; Warzok RW; Hufnagl P; Roth K
Clin Neuropathol; 1995; 14(1):55-61. PubMed ID: 7729083
[TBL] [Abstract][Full Text] [Related]
36. Measuring of AgNORs using image analysis.
Hufnagl P; Guski H; Schulz HJ
Zentralbl Pathol; 1994 Mar; 140(1):31-5. PubMed ID: 7515670
[TBL] [Abstract][Full Text] [Related]
37. Quantitative analysis of three-dimensional distribution of AgNOR proteins during interphase in leukemic cells.
Wozniak ZM; Usson Y; Parazza F; Champelovier P; Leroux D; Seigneurin D
Cytometry; 1996 May; 24(1):14-26. PubMed ID: 8723898
[TBL] [Abstract][Full Text] [Related]
38. [Significance of AgNOR analysis of urothelial carcinomas].
Helpap B; Loesevitz L
Verh Dtsch Ges Pathol; 1993; 77():222-5. PubMed ID: 7511285
[TBL] [Abstract][Full Text] [Related]
39. Agnor as a marker of malignant transformation in odontogenic keratocysts.
Piloni MJ; Keszler A; Itoiz ME
Acta Odontol Latinoam; 2005; 18(1):37-42. PubMed ID: 16302459
[TBL] [Abstract][Full Text] [Related]
40. Silver-binding nucleolar organizer regions (AgNORs) in bronchial tumors.
Zaczek M; Chłap Z; Szot W; Gil K; Hajduk A
Folia Histochem Cytobiol; 1995; 33(2):83-8. PubMed ID: 8617383
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
